New Zealand announces new trial for treatment-resistant depression

Researchers at the University of Otago in New Zealand are recruiting for a novel trial, combining use of the drug ketami...

April 5, 2024 | Friday | News
New discovery by Australia unravels malaria invasion mechanism

In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and...

April 4, 2024 | Thursday | News
Lion TCR partners with NUSGRTII in Singapore to drive innovation in biomedical research

Lion TCR has forged a strategic partnership with the National University of Singapore Guangzhou Research Translation and...

March 28, 2024 | Thursday | News
Breakthrough antibiotic by Singapore shows promise against obstinate mycobacterial infections

Researchers from the Institute for Functional Intelligent Materials (I-FIM) at the National University of Singapore (NUS...

March 28, 2024 | Thursday | News
Charles River extends gene therapy manufacturing alliance with NUS Yong Loo Lin School of Medicine in Singapore

US-based Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yon...

March 21, 2024 | Thursday | News
BioNTech, GSK, Sanofi, NTU, NTUitive, NUS and SIT joins forces with BioPIPS in Singapore

The Biologics Pharma Innovation Programme Singapore (BioPIPS) consortium has strengthened its competencies by partnering...

March 19, 2024 | Tuesday | News
Australian government provides grant worth $3 M for better wound care

The hidden epidemic of chronic wounds in Australia will be tackled through new initiatives funded with more than $3 mill...

March 18, 2024 | Monday | News
Novartis expands its biopharmaceutical manufacturing site in Singapore

Novartis is investing $256 million to expand its biopharmaceutical manufacturing plant in Singapore. The extended s...

March 15, 2024 | Friday | Company results
Zika virus vaccine emerges as tool in battling brain cancer: Singaporean study

Scientists from Duke-NUS Medical School (Duke-NUS) at Singapore have developed a new approach using the Zika virus to de...

March 11, 2024 | Monday | News
Taiwan’s BioGate Precision Medicine Corp develops pancreatic cancer therapy

Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...

March 7, 2024 | Thursday | News
First ever large-scale GMP manufacturing of therapeutic IgE antibody achieved in the UK

Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...

March 5, 2024 | Tuesday | News
Novel platform can significantly reduces drug testing and screening time in cancer diagnosis

In a breakthrough for personalised oncology, scientists from the National University of Singapore (NUS) and the National...

March 4, 2024 | Monday | News
Korea develops implant coating triggering antibiotic release against bacterial infection

A collaborative research team from the Department of Chemical Engineering and the School of Convergence Science and Tech...

March 4, 2024 | Monday | News
"One example of success is the development of a potential new paediatric treatment for schistosomiasis"

Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...

March 1, 2024 | Friday | Opinion
Korea using new rapid test for early outbreak control of Hantavirus

Orthohantaviruses, highly transmissible zoonotic pathogens, are notorious for causing haemorrhagic fever with renal synd...

March 1, 2024 | Friday | News
Malaysia's trajectory in redefining Cancer Treatment Standards

As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earni...

February 22, 2024 | Thursday | Analysis
Daiichi Sankyo unveils APAC regional hub for RDPV QA operations in Singapore

Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...

February 22, 2024 | Thursday | Company results
Singapore approves AffaMed Therapeutics drug for Ocular Inflammation

China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...

February 21, 2024 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls